LC
HURA

Lindbrook Capital’s TuHURA Biosciences HURA Stock Holding History

Lindbrook Capital’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-61
Closed -$14.7K – 2932
2022
Q4 		$14.7K Buy
+61
New +$13.6K ﹤0.01% 1231
2022
Q2 		– Sell
-1
Closed -$1K – 2812
2022
Q1 		$1K Hold
1
– – ﹤0.01% 2409
2021
Q4 		$1K Hold
1
– – ﹤0.01% 2024
2021
Q3 		$2K Sell
1
-2
-67% -$5.25K ﹤0.01% 1634
2021
Q2 		$12K Buy
3
+1
+50% +$2.87K ﹤0.01% 994
2021
Q1 		$7K Buy
2
+1
+100% +$3.4K ﹤0.01% 1178
2020
Q4 		$1K Buy
+1
New +$2.51K ﹤0.01% 1719

Other funds holding HURA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lindbrook Capital's HURA Position: Q1 2023 in Review

Lindbrook Capital sold out of TuHURA Biosciences (HURA) in Q1 2023, closing a stake of 61 shares — an estimated $14.7K sold.

Lindbrook Capital first reported a position in HURA in Q4 2020 and held it in 7 quarters. The position peaked at $14.7K in Q4 2022. 9 funds tracked by Wall St. Rank hold HURA as of Q1 2023.

  • Lindbrook Capital reported no remaining TuHURA Biosciences position as of Q1 2023 after selling out during the quarter.
  • Lindbrook Capital sold 61 TuHURA Biosciences shares in Q1 2023, an estimated $14.7K.
  • Lindbrook Capital first reported a position in TuHURA Biosciences in Q4 2020 and held it in 7 quarters.
  • Lindbrook Capital's TuHURA Biosciences position peaked at $14.7K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.